Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells.
about
Targeting the Brain Reservoirs: Toward an HIV CureHIV-1 Latency-Reversing Agents Prostratin and Bryostatin-1 Induce Blood-Brain Barrier Disruption/Inflammation and Modulate Leukocyte Adhesion/Transmigration.A Critical Review of the Evidence Concerning the HIV Latency Reversing Effect of Disulfiram, the Possible Explanations for Its Inability to Reduce the Size of the Latent Reservoir In Vivo, and the Caveats Associated with Its Use in Practice.Contrasting effect of the latency-reversing agents bryostatin-1 and JQ1 on astrocyte-mediated neuroinflammation and brain neutrophil invasion.
P2860
Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells.
@en
type
label
Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells.
@en
prefLabel
Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells.
@en
P2093
P2860
P1476
Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells.
@en
P2093
Anne M Ellett
Catherine Papaioannou
Damian F J Purcell
Emma Roberts
Jacqueline A Raison
Jonathan C Jacobson
Lachlan R Gray
Melissa J Churchill
P2860
P2888
P304
P356
10.1007/S13365-015-0413-4
P577
2016-01-04T00:00:00Z